Skip to content
777 Sourcing.

Capability

cell-based assay development

Suppliers
1
States & provinces
1
Countries
1

1 cell-based assay development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CHEMESTMED OU

TARTU, TARTU

Chemestmed is an Estonian biotech company developing first-in-class drugs to treat CNS and metabolic diseases and disorders. It works in epitranscriptomics, developing a technological platform for discovery of novel drugs based on mRNA regulation in cells, including small-molecule activators targeting the METTL3/METTL14 methyltransferase complex to enhance RNA m⁶A methylation.

CRISPR/Cas9 gene editingenzyme assaysepitranscriptomics researchin vitro cell culturemolecular modelingNMR analysisorganic synthesisquantum chemistry calculationssmall molecule drug discoveryvirtual screening

Compiled from public sources

Related capabilities

Other processes offered by the shops that list cell-based assay development.

Browse all capabilities